marketcaparena
Search

    CVKD

    Cadrenal Therapeutics, Inc.

    Company overview

    Market capitalization
    $4.00M
    Employees
    5
    Latest publication
    2026-09-29
    About Cadrenal Therapeutics, Inc.

    Cadrenal Therapeutics, Inc. operates as a late-stage biopharmaceutical company that develops novel therapies for life-threatening immune and thrombotic conditions. The company is developing Tecarfarin, an oral vitamin K antagonist that is in Phase 3 clinical trial designed to prevent heart attacks, strokes, and deaths due to blood clots in patients requiring chronic anticoagulation, such as patients with left ventricular assist devices, end-stage kidney disease, and atrial fibrillation; CAD-1005, a first-in-class 12-LOX inhibitor for the treatment of heparin-induced thrombocytopenia, a deadly immune-mediated thrombotic disorder that has completed Phase 2 clinical trial; and Frunexian, a parenteral clinical-stage factor XIa inhibitor designed for use in acute hospital settings that has completed Phase 1 clinical trial. It has a collaboration agreement with Abbott Global Enterprises Limited to evaluate the efficacy and safety of Tecarfarin in patients with a left-ventricular assist device. The company was incorporated in 2022 and is headquartered in Ponte Vedra, Florida.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Total Revenue0USD0USD0USD0USD0USD2,134USD0USD0USD
    Cost Of Revenue555USD555USD401USD401USD5,517USD1,067USD407USD470USD
    Gross Profit-555USD-555USD-401USD-401USD-5,517USD1,067USD-407USD-470USD
    Research Development771,508USD666,323USD688,465USD1,077,498USD1,667,882USD1,537,631USD784,646USD1,253,711USD
    Selling General Administrative1,742,315USD2,398,228USD2,044,937USD2,656,392USD2,254,577USD2,740,390USD1,674,905USD1,212,437USD
    Total Operating Expenses2,514,378USD3,065,106USD2,733,402USD3,734,291USD3,922,459USD4,278,428USD2,459,958USD2,466,618USD
    Operating Income-2,514,378USD-3,065,106USD-2,733,803USD-3,734,291USD-3,927,976USD-4,278,428USD-2,459,958USD-2,466,618USD
    Interest Income17,838USD26,116USD48,098USD67,004USD82,596USD91,159USD52,129USD73,636USD
    Net Interest Income17,838USD26,116USD48,098USD67,004USD82,596USD91,159USD52,129USD73,636USD
    Income Before Tax-2,496,540USD-3,038,990USD-2,685,705USD-3,667,287USD-3,845,380USD-4,187,269USD-2,407,829USD-2,392,982USD
    Net Income-2,496,540USD-3,038,990USD-2,685,705USD-3,667,287USD-3,845,380USD-4,187,269USD-2,407,829USD-2,392,982USD
    Net Income From Continuing Ops-2,496,540USD-3,038,990USD-2,685,705USD-3,667,287USD-3,845,380USD-4,187,269USD-2,407,829USD-2,392,982USD
    Ebit-2,514,933USD-3,065,106USD-2,685,705USD-3,734,291USD-3,845,380USD-4,187,269USD-2,407,829USD-2,466,618USD
    Ebitda-2,514,378USD-3,064,551USD-2,685,304USD-3,733,890USD-3,839,863USD-4,186,862USD-2,407,422USD-2,466,148USD
    Depreciation And Amortization555USD555USD401USD401USD5,517USD407USD407USD470USD
    Reconciled Depreciation555USD555USD401USD401USD5,517USD407USD406USD470USD
    Total Other Income Expense Net17,838USD26,116USD48,098USD67,004USD82,596USD91,159USD52,129USD73,636USD
    Interest Expense—————0USD0USD0USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USD
    Total Revenue0USD0USD0USD—
    Research Development4,100,168USD4,205,013USD4,081,349USD392,859USD
    Selling General Administrative9,354,135USD6,753,726USD3,549,514USD—
    Total Operating Expenses13,461,177USD10,960,619USD7,632,843USD2,700,362USD
    Operating Income-13,461,177USD-10,960,619USD-7,632,843USD-2,701,630USD
    Interest Income223,815USD309,251USD249,092USD—
    Net Interest Income223,815USD309,251USD231,991USD—
    Income Before Tax-13,237,362USD-10,651,368USD-8,357,086USD-6,714,329USD
    Net Income-13,237,362USD-10,651,368USD-8,357,086USD-6,714,329USD
    Net Income From Continuing Ops-13,237,362USD-10,651,368USD-8,357,086USD—
    Ebit-13,468,051USD-10,651,368USD-8,339,985USD-6,607,224USD
    Ebitda-13,461,177USD-10,649,488USD-8,338,005USD-6,605,958USD
    Depreciation And Amortization6,874USD1,880USD1,980USD1,266USD
    Reconciled Depreciation6,874USD1,880USD1,980USD—
    Total Other Income Expense Net223,815USD309,251USD-724,243USD-4,012,699USD
    Cost Of Revenue—1,880USD1,980USD1,266USD
    Gross Profit—-1,880USD-1,980USD-1,266USD
    Interest Expense—0USD17,101USD107,105USD
    Income Tax Expense——-165,915USD4USD
    Unclassified Operating Expenses———2,307,503USD
    Net Income Applicable To Common Shares———-7,324,722USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets5,588,965USD2,862,067USD4,326,708USD4,087,622USD5,978,431USD7,953,262USD10,123,533USD4,679,293USD
    Cash And Equivalents2,388,135USD———————
    Total Current Assets5,584,123USD2,855,281USD4,319,367USD4,079,726USD5,971,987USD7,944,792USD10,112,797USD4,672,490USD
    Other Current Assets410,105USD541,678USD306,482USD206,853USD382,218USD584,056USD56,702USD308,590USD
    Other Non Current Assets2,167USD———————
    Total Liabilities1,497,257USD———————
    Total Current Liabilities1,497,257USD1,064,952USD1,587,982USD1,352,675USD1,679,518USD1,840,166USD2,683,958USD1,266,942USD
    Other Current Liabilities625,344USD———————
    Total Stockholder Equity4,091,708USD1,797,115USD2,738,726USD2,734,947USD4,298,913USD6,113,096USD7,439,575USD3,412,351USD
    Total Equity Including Noncontrolling Interest4,091,708USD———————
    Property Plant Equipment Net2,675USD4,619USD5,174USD5,729USD4,277USD4,678USD6,944USD3,011USD
    Accounts Payable871,913USD824,809USD650,663USD614,127USD895,609USD1,278,402USD1,502,468USD496,823USD
    Common Stock3,098USD2,507USD2,338USD2,059USD2,006USD1,909USD1,782USD1,234USD
    Retained Earnings-44,779,250USD-41,456,685USD-38,960,145USD-35,921,155USD-33,235,450USD-29,568,163USD-25,722,783USD-21,535,514USD
    Total Liab—1,064,952USD1,587,982USD1,352,675USD1,679,518USD1,840,166USD2,683,958USD1,266,942USD
    Other Current Liab—240,143USD937,319USD738,548USD783,909USD561,764USD1,181,490USD767,887USD
    Capital Stock—2,507USD2,338USD2,059USD2,006USD1,909USD1,782USD1,234USD
    Cash—2,308,137USD4,007,789USD3,860,082USD5,570,730USD7,336,072USD10,017,942USD4,363,900USD
    Cash And Short Term Investments—2,308,137USD4,007,789USD3,860,082USD5,570,730USD7,336,072USD10,017,942USD4,363,900USD
    Net Debt—-2,308,137USD-4,007,789USD-3,860,082USD-5,570,730USD-7,336,072USD-10,017,942USD-4,361,668USD
    Net Receivables—5,466USD5,096USD12,791USD19,039USD24,664USD38,153USD—
    Property Plant Equipment Gross—4,619USD5,174USD—4,277USD—6,944USD3,011USD
    Common Stock Shares Outstanding—2,407,665shares1,993,757shares2,044,033shares1,961,642shares1,844,072shares1,525,005shares1,104,005shares
    Non Current Assets Total—6,786USD7,341USD7,896USD6,444USD8,470USD10,736USD6,803USD
    Non Current Liabilities Total—0USD0USD0USD0USD0USD0USD0USD
    Non Currrent Assets Other—2,167USD2,167USD2,167USD2,167USD3,792USD3,792USD3,792USD
    Net Working Capital—1,790,329USD2,731,385USD2,727,051USD4,292,469USD6,104,626USD7,428,839USD3,405,548USD
    Unclassified Equity—43,248,786USD41,694,195USD38,651,984USD37,530,351USD35,677,441USD33,158,794USD24,945,397USD
    Short Term Debt———————2,232USD
    Short Long Term Debt Total———————2,232USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USD
    Total Assets4,326,708USD10,123,533USD8,519,250USD778,174USD
    Other Current Assets306,482USD56,702USD89,673USD695,010USD
    Total Liab1,587,982USD2,683,958USD826,875USD6,329,324USD
    Total Stockholder Equity2,738,726USD7,439,575USD7,692,375USD-5,551,150USD
    Other Current Liab937,319USD1,181,490USD638,206USD863,564USD
    Common Stock2,338USD1,782USD13,022USD8,194USD
    Capital Stock2,338USD1,782USD13,022USD8,194USD
    Retained Earnings-38,960,145USD-25,722,783USD-15,071,415USD-6,714,329USD
    Cash4,007,789USD10,017,942USD8,402,500USD32,586USD
    Cash And Short Term Investments4,007,789USD10,017,942USD8,402,500USD32,586USD
    Total Current Assets4,319,367USD10,112,797USD8,492,173USD727,596USD
    Total Current Liabilities1,587,982USD2,683,958USD826,875USD1,334,477USD
    Net Debt-4,007,789USD-10,017,942USD-8,381,150USD608,120USD
    Net Receivables5,096USD38,153USD——
    Accounts Payable650,663USD1,502,468USD167,319USD404,897USD
    Property Plant Equipment Net5,174USD6,944USD23,285USD44,591USD
    Property Plant Equipment Gross5,174USD6,944USD23,285USD44,591USD
    Common Stock Shares Outstanding1,993,757shares1,219,550shares868,183shares775,638shares
    Non Current Assets Total7,341USD10,736USD27,077USD50,578USD
    Non Current Liabilities Total0USD0USD0USD4,994,847USD
    Non Currrent Assets Other2,167USD3,792USD3,792USD-526,013USD
    Net Working Capital2,731,385USD7,428,839USD7,665,298USD-606,881USD
    Unclassified Equity41,694,195USD33,158,794USD22,737,746USD1,146,791USD
    Current Deferred Revenue——532,706USD—
    Short Term Debt——21,350USD66,016USD
    Short Long Term Debt Total——21,350USD640,706USD
    Other Liab———4,420,157USD
    Other Assets———5,987USD
    Short Long Term Debt———43,728USD
    Long Term Debt———553,340USD
    Net Tangible Assets———-5,551,150USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Depreciation1,059USD
    Stock Based Compensation924,466USD
    Change To Liabilities-142,285USD
    Change In Working Capital221,250USD
    Operating Cash Flow-5,235,371USD
    Investing Cash Flow1,441USD
    Financing Cash Flow3,614,276USD
    Change In Cash-1,619,654USD
    End Cash Flow2,388,135USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-2,496,540USD-3,038,990USD-2,685,705USD-3,667,287USD-3,845,380USD-4,187,269USD-2,407,829USD-2,392,982USD
    Depreciation555USD555USD401USD401USD5,517USD407USD406USD470USD
    Stock Based Compensation252,364USD325,103USD473,384USD592,644USD548,765USD763,208USD299,980USD193,120USD
    Other Non Cash Items-758,596USD2,810,247USD473,384USD—548,765USD-35USD-106USD-106USD
    Change To Account Receivables-370USD7,695USD6,248USD5,625USD13,489USD——8,099USD
    Change In Working Capital-758,596USD143,373USD-145,230USD48,440USD-1,357,657USD1,632,983USD-93,671USD670,254USD
    Total Cash From Operating Activities-3,002,217USD-2,569,959USD-2,357,150USD-3,025,802USD-4,648,755USD-1,790,706USD-2,201,220USD-1,529,244USD
    Capital Expenditures-3USD-3,255USD-1,850USD-3,255USD-3,255USD-6,537USD0USD0USD
    Free Cash Flow-3,002,217USD-2,569,959USD-2,359,000USD-3,025,802USD-4,652,010USD-1,797,243USD-2,201,220USD-1,529,244USD
    Total Cash From Financing Activities1,302,565USD2,717,666USD648,355USD1,260,460USD1,970,136USD7,451,285USD1,527,946USD0USD
    Issuance Of Capital Stock1,366,535USD3,096,116USD683,983USD1,324,144USD2,055,471USD3,615,648USD1,527,946USD0USD
    Change In Cash-1,699,652USD147,707USD-1,710,648USD-1,765,342USD-2,681,870USD5,654,042USD-673,274USD-1,529,244USD
    Begin Period Cash Flow4,007,789USD3,860,082USD5,570,730USD7,336,072USD10,017,942USD4,363,900USD5,037,174USD6,566,418USD
    End Period Cash Flow2,308,137USD4,007,789USD3,860,082USD5,570,730USD7,336,072USD10,017,942USD4,363,900USD5,037,174USD
    Other Cashflows From Financing Activities1,302,565USD-378,450USD648,355USD-63,684USD-85,335USD3,835,637USD1,527,946USD—
    Unclassified Financing Cash Flow-1,366,535USD—————-1,527,946USD—
    Total Cashflows From Investing Activities—-3,251USD-1,853USD3,251USD-3,251USD-6,537USD——
    Unclassified Operating Cash Flow—-2,810,247USD——————
    Investments——-1,853USD0USD-3,251USD-6,537USD0USD0USD
    Other Cashflows From Investing Activities——-5,104USD—-3,251USD———
    Net Borrowings—————0USD0USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USD
    Net Income-13,237,362USD-10,651,368USD-8,357,086USD-6,714,329USD
    Depreciation6,874USD1,880USD1,980USD1,266USD
    Stock Based Compensation1,939,896USD1,419,039USD710,381USD—
    Other Non Cash Items-1,311,074USD-352USD3,970,093USD4,900,558USD
    Change To Account Receivables33,057USD———
    Change In Working Capital-1,311,074USD1,873,251USD144,309USD607,735USD
    Total Cash From Operating Activities-12,601,666USD-7,357,550USD-3,530,323USD-1,204,770USD
    Capital Expenditures-5,104USD-6,537USD-3,254USD-2,486USD
    Free Cash Flow-12,601,666USD-7,364,087USD-3,533,577USD-1,204,770USD
    Total Cashflows From Investing Activities-5,104USD-6,537USD-3,254USD-2,279USD
    Total Cash From Financing Activities6,596,617USD8,979,529USD11,903,491USD1,239,635USD
    Sale Purchase Of Stock-291,883USD0USD——
    Issuance Of Capital Stock7,159,714USD5,143,594USD11,903,491USD—
    Change In Cash-6,010,153USD1,615,442USD8,369,914USD32,585USD
    Begin Period Cash Flow10,017,942USD8,402,500USD32,586USD-1USD
    End Period Cash Flow4,007,789USD10,017,942USD8,402,500USD32,585USD
    Other Cashflows From Investing Activities-5,104USD-6,537USD——
    Other Cashflows From Financing Activities-271,214USD3,835,935USD250,000USD-2,279USD
    Unclassified Operating Cash Flow1,311,074USD———
    Unclassified Financing Cash Flow7,159,714USD5,143,594USD——
    Investments—-6,537USD-3,254USD—
    Net Borrowings—0USD-250,000USD1,343,656USD
    Change To Liabilities———441,706USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    No revenue breakdown is currently published for this company.

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.